Grifols, S.A.

Grifols, S.A., is a leading global healthcare company that specializes in producing and supplying essential plasma-derived medicines. Founded in 1909 and headquartered in Barcelona, Spain, Grifols is at the forefront of biotechnology and pharmaceuticals, particularly in the area of hematology. The company operates through several divisions, including Bioscience, Diagnostic, Hospital, and Bio Supplies, each focusing on various aspects of healthcare. One of Grifols' primary functions is the collection and processing of human plasma to develop therapies for conditions such as immune deficiencies, coagulation disorders, and neurological diseases. The company's Bioscience division is vital in the global plasma market, providing critical therapies that improve patients' quality of life. Moreover, Grifols' Diagnostic division offers advanced diagnostic solutions across blood testing, transfusion medicine, and clinical genomics, which enhance the safety and efficacy of transfusion processes. With a significant presence in both the European and North American markets, Grifols plays a crucial role in the healthcare industry by not only supplying vital medications but also driving innovation in blood safety and efficiency. Through strategic acquisitions and investments in R&D, Grifols continues to expand its capabilities in biotechnology and plasma-derived therapies.